{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:21:11Z","timestamp":1792819271453,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T00:00:00Z","timestamp":1628035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T00:00:00Z","timestamp":1628035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>To assess the effect from individual component in combinations of steroid, ascorbic acid, and thiamine on outcomes in adults with sepsis and septic shock with component network meta-analysis (NMA). We searched PubMed, EMBASE, and the Cochrane Library Central Register of Controlled Trials from 1980 to March 2021 for randomized controlled trials (RCT) that studied the use of glucocorticoid, fludrocortisone, ascorbic acid, and thiamine in patients with sepsis and septic shock. Citations screening, study selection, data extraction, and risk of bias assessment were independently performed by two authors. The primary outcome was short-term mortality. Secondary outcomes were longer-term mortality, time to resolution of shock and duration of mechanical ventilation. Thirty-three RCTs including 9898 patients presented on short-term mortality. In additive component NMA, patients on ascorbic acid alone (RR 0.74, 95% CI 0.57\u20130.97) or the combination of glucocorticoid and fludrocortisone (RR 0.89, 95% CI 0.80\u20130.99) had lower short-term mortality, but only the latter was associated with improved long-term mortality (RR 0.89, 95% CI 0.82\u20130.98). The use of glucocorticoid or the combination of glucocorticoid, ascorbic acid and thiamine hastened resolution of shock. Component NMA showed glucocorticoid (MD \u2212\u00a00.96, 95% CI \u2212\u00a01.61 to \u2212\u00a00.30) but not ascorbic acid or thiamine shortened the time to resolution of shock. Glucocorticoid shortened the duration of mechanical ventilation (MD \u2212\u00a01.48, 95% CI \u2212\u00a02.43 to \u2212\u00a00.52). In adults with sepsis and septic shock, the combination of glucocorticoid and fludrocortisone improved short-term and longer-term mortality. Glucocorticoid shortened the time to resolution of shock and duration of mechanical ventilation. There was no strong evidence supporting the routine use of thiamine and ascorbic acid, but they were associated with minimal adverse effects.<\/jats:p>","DOI":"10.1038\/s41598-021-95386-9","type":"journal-article","created":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T06:04:26Z","timestamp":1628057066000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Steroid, ascorbic acid, and thiamine in adults with sepsis and septic shock: a systematic review and component network meta-analysis"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1491-5335","authenticated-orcid":false,"given":"Ka Man","family":"Fong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shek Yin","family":"Au","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George Wing Yiu","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,4]]},"reference":[{"issue":"4","key":"95386_CR1","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1097\/00003246-199904000-00025","volume":"27","author":"J Briegel","year":"1999","unstructured":"Briegel, J. et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective, randomized, double-blind, single-center study. Crit. Care Med. 27(4), 723\u2013732 (1999).","journal-title":"Crit. Care Med."},{"issue":"4","key":"95386_CR2","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1590\/S1516-31802007000400009","volume":"125","author":"DD Cicarelli","year":"2007","unstructured":"Cicarelli, D. D., Vieira, J. E. & Bensenor, F. E. Early dexamethasone treatment for septic shock patients: A prospective randomized clinical trial. Sao Paulo Med. J. 125(4), 237\u2013241 (2007).","journal-title":"Sao Paulo Med. J."},{"issue":"2","key":"95386_CR3","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa071366","volume":"358","author":"CL Sprung","year":"2008","unstructured":"Sprung, C. L. et al. Hydrocortisone therapy for patients with septic shock. N. Engl. J. Med. 358(2), 111\u2013124 (2008).","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"95386_CR4","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1097\/CCM.0000000000000212","volume":"42","author":"AC Gordon","year":"2014","unstructured":"Gordon, A. C. et al. The interaction of vasopressin and corticosteroids in septic shock: A pilot randomized controlled trial. Crit. Care Med. 42(6), 1325\u20131333 (2014).","journal-title":"Crit. Care Med."},{"issue":"6","key":"95386_CR5","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.chest.2016.11.036","volume":"151","author":"PE Marik","year":"2017","unstructured":"Marik, P. E., Khangoora, V., Rivera, R., Hooper, M. H. & Catravas, J. Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock: A retrospective before-after study. Chest 151(6), 1229\u20131238 (2017).","journal-title":"Chest"},{"issue":"5","key":"95386_CR6","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1001\/jama.2019.22176","volume":"323","author":"T Fujii","year":"2020","unstructured":"Fujii, T. et al. Effect of vitamin C, hydrocortisone, and thiamine vs hydrocortisone alone on time alive and free of vasopressor support among patients with septic shock: The VITAMINS randomized clinical trial. JAMA 323(5), 423\u2013431 (2020).","journal-title":"JAMA"},{"issue":"9","key":"95386_CR7","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1093\/aje\/kwp014","volume":"169","author":"NJ Welton","year":"2009","unstructured":"Welton, N. J., Caldwell, D. M., Adamopoulos, E. & Vedhara, K. Mixed treatment comparison meta-analysis of complex interventions: Psychological interventions in coronary heart disease. Am. J. Epidemiol. 169(9), 1158\u20131165 (2009).","journal-title":"Am. J. Epidemiol."},{"issue":"3","key":"95386_CR8","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/bimj.201800167","volume":"62","author":"G Rucker","year":"2020","unstructured":"Rucker, G., Petropoulou, M. & Schwarzer, G. Network meta-analysis of multicomponent interventions. Biom. J. 62(3), 808\u2013821 (2020).","journal-title":"Biom. J."},{"key":"95386_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jclinepi.2018.02.012","volume":"98","author":"SC Freeman","year":"2018","unstructured":"Freeman, S. C. et al. Component network meta-analysis identifies the most effective components of psychological preparation for adults undergoing surgery under general anesthesia. J. Clin. Epidemiol. 98, 105\u2013116 (2018).","journal-title":"J. Clin. Epidemiol."},{"issue":"2","key":"95386_CR10","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1136\/jnnp-2020-323870","volume":"92","author":"CS Chu","year":"2021","unstructured":"Chu, C. S. et al. Cognitive effects and acceptability of non-invasive brain stimulation on Alzheimer\u2019s disease and mild cognitive impairment: a component network meta-analysis. J. Neurol. Neurosurg. Psychiatry 92(2), 195\u2013203 (2021).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"95386_CR11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1001\/jamapsychiatry.2020.2993","volume":"78","author":"DJ Miklowitz","year":"2021","unstructured":"Miklowitz, D. J. et al. Adjunctive psychotherapy for bipolar disorder: A systematic review and component network meta-analysis. JAMA Psychiat. 78(2), 141\u2013150 (2021).","journal-title":"JAMA Psychiat."},{"issue":"11","key":"95386_CR12","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/M14-2385","volume":"162","author":"B Hutton","year":"2015","unstructured":"Hutton, B. et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: Checklist and explanations. Ann Intern Med. 162(11), 777\u2013784 (2015).","journal-title":"Ann Intern Med."},{"key":"95386_CR13","unstructured":"Higgins, J. P. T. S. J., Savovi\u0107, J., Page, M. J., Hr\u00f3bjartsson, A., Boutron, I., Reeves, B. & Eldridge, S. A revised tool for assessing risk of bias in randomized trials. Cochrane database of systematic reviews. 10(Suppl 1), 297\u201331 (2016)."},{"key":"95386_CR14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan, X., Wang, W., Liu, J. & Tong, T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med. Res. Methodol. 14, 135 (2014).","journal-title":"BMC Med. Res. Methodol."},{"key":"95386_CR15","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12874-015-0060-8","volume":"15","author":"G Rucker","year":"2015","unstructured":"Rucker, G. & Schwarzer, G. Ranking treatments in frequentist network meta-analysis works without resampling methods. BMC Med. Res. Methodol. 15, 58 (2015).","journal-title":"BMC Med. Res. Methodol."},{"issue":"2","key":"95386_CR16","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/jrsm.1044","volume":"3","author":"JP Higgins","year":"2012","unstructured":"Higgins, J. P. et al. Consistency and inconsistency in network meta-analysis: Concepts and models for multi-arm studies. Res. Synth. Methods 3(2), 98\u2013110 (2012).","journal-title":"Res. Synth. Methods"},{"issue":"3","key":"95386_CR17","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","volume":"43","author":"A Rhodes","year":"2017","unstructured":"Rhodes, A. et al. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 43(3), 304\u2013377 (2017).","journal-title":"Intensive Care Med."},{"issue":"1","key":"95386_CR18","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13054-017-1659-4","volume":"21","author":"B Gibbison","year":"2017","unstructured":"Gibbison, B. et al. Corticosteroids in septic shock: A systematic review and network meta-analysis. Crit. Care. 21(1), 78 (2017).","journal-title":"Crit. Care."},{"issue":"18","key":"95386_CR19","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1056\/NEJM198411013111801","volume":"311","author":"CL Sprung","year":"1984","unstructured":"Sprung, C. L. et al. The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study. N. Engl. J. Med. 311(18), 1137\u20131143 (1984).","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"95386_CR20","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1056\/NEJM198709103171101","volume":"317","author":"RC Bone","year":"1987","unstructured":"Bone, R. C. et al. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N. Engl. J. Med. 317(11), 653\u2013658 (1987).","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"95386_CR21","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1164\/ajrccm\/138.1.62","volume":"138","author":"JM Luce","year":"1988","unstructured":"Luce, J. M. et al. Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am. Rev. Respir. Dis. 138(1), 62\u201368 (1988).","journal-title":"Am. Rev. Respir. Dis."},{"issue":"11","key":"95386_CR22","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1056\/NEJM198709103171102","volume":"317","author":"Veterans Administration Systemic Sepsis Cooperative Study G","year":"1987","unstructured":"Veterans Administration Systemic Sepsis Cooperative Study G. Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N. Engl. J. Med. 317(11), 659\u2013665 (1987).","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"95386_CR23","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1097\/01.CCM.0000186370.78639.23","volume":"33","author":"M Oppert","year":"2005","unstructured":"Oppert, M. et al. Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit. Care Med. 33(11), 2457\u20132464 (2005).","journal-title":"Crit. Care Med."},{"key":"95386_CR24","doi-asserted-by":"publisher","first-page":"g5630","DOI":"10.1136\/bmj.g5630","volume":"349","author":"MA Puhan","year":"2014","unstructured":"Puhan, M. A. et al. A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis. BMJ 349, g5630 (2014).","journal-title":"BMJ"},{"issue":"4","key":"95386_CR25","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","volume":"64","author":"H Balshem","year":"2011","unstructured":"Balshem, H. et al. GRADE guidelines: 3. Rating the quality of evidence. J. Clin. Epidemiol. 64(4), 401\u2013406 (2011).","journal-title":"J. Clin. Epidemiol."},{"issue":"7","key":"95386_CR26","doi-asserted-by":"publisher","first-page":"e99682","DOI":"10.1371\/journal.pone.0099682","volume":"9","author":"G Salanti","year":"2014","unstructured":"Salanti, G., Del Giovane, C., Chaimani, A., Caldwell, D. M. & Higgins, J. P. Evaluating the quality of evidence from a network meta-analysis. PLoS ONE 9(7), e99682 (2014).","journal-title":"PLoS ONE"},{"issue":"4","key":"95386_CR27","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1097\/00003246-199804000-00010","volume":"26","author":"PE Bollaert","year":"1998","unstructured":"Bollaert, P. E. et al. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit. Care Med. 26(4), 645\u2013650 (1998).","journal-title":"Crit. Care Med."},{"issue":"7","key":"95386_CR28","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1001\/jama.288.7.862","volume":"288","author":"D Annane","year":"2002","unstructured":"Annane, D. et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288(7), 862\u2013871 (2002).","journal-title":"JAMA"},{"issue":"4_MeetingAbstra","key":"95386_CR29","doi-asserted-by":"publisher","first-page":"45S","DOI":"10.1016\/S0012-3692(16)48001-3","volume":"136","author":"GU Meduri","year":"2009","unstructured":"Meduri, G. U., Golden, E. & Umberger, R. Prospective double-blind randomized clinical trial on the effects of low-dose hydrocortisone infusion in patients with severe sepsis. Chest 136(4_MeetingAbstracts), 45S (2009).","journal-title":"Chest"},{"issue":"4","key":"95386_CR30","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1001\/jama.2010.2","volume":"303","author":"CS Investigators","year":"2010","unstructured":"Investigators, C. S. et al. Corticosteroid treatment and intensive insulin therapy for septic shock in adults: A randomized controlled trial. JAMA 303(4), 341\u2013348 (2010).","journal-title":"JAMA"},{"issue":"2","key":"95386_CR31","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/CCM.0000000000001572","volume":"44","author":"MW Donnino","year":"2016","unstructured":"Donnino, M. W. et al. Randomized, double-blind, placebo-controlled trial of thiamine as a metabolic resuscitator in septic shock: A pilot study. Crit. Care Med. 44(2), 360\u2013367 (2016).","journal-title":"Crit. Care Med."},{"issue":"2","key":"95386_CR32","doi-asserted-by":"publisher","first-page":"94","DOI":"10.4103\/2279-042X.179569","volume":"5","author":"MH Zabet","year":"2016","unstructured":"Zabet, M. H., Mohammadi, M., Ramezani, M. & Khalili, H. Effect of high-dose Ascorbic acid on vasopressor\u2019s requirement in septic shock. J. Res. Pharm. Pract. 5(2), 94\u2013100 (2016).","journal-title":"J. Res. Pharm. Pract."},{"issue":"5","key":"95386_CR33","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1001\/jama.2016.10485","volume":"316","author":"AC Gordon","year":"2016","unstructured":"Gordon, A. C. et al. Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: The VANISH randomized clinical trial. JAMA 316(5), 509\u2013518 (2016).","journal-title":"JAMA"},{"issue":"1","key":"95386_CR34","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s13054-016-1511-2","volume":"20","author":"S Tongyoo","year":"2016","unstructured":"Tongyoo, S. et al. Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: Results of a randomized controlled trial. Crit. Care 20(1), 329 (2016).","journal-title":"Crit. Care"},{"issue":"12","key":"95386_CR35","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1016\/j.ajem.2017.06.004","volume":"35","author":"QQ Lv","year":"2017","unstructured":"Lv, Q. Q., Gu, X. H., Chen, Q. H., Yu, J. Q. & Zheng, R. Q. Early initiation of low-dose hydrocortisone treatment for septic shock in adults: A randomized clinical trial. Am. J. Emerg. Med. 35(12), 1810\u20131814 (2017).","journal-title":"Am. J. Emerg. Med."},{"issue":"9","key":"95386_CR36","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1056\/NEJMoa1705716","volume":"378","author":"D Annane","year":"2018","unstructured":"Annane, D. et al. Hydrocortisone plus fludrocortisone for adults with septic shock. N. Engl. J. Med. 378(9), 809\u2013818 (2018).","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"95386_CR37","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1056\/NEJMoa1705835","volume":"378","author":"B Venkatesh","year":"2018","unstructured":"Venkatesh, B. et al. Adjunctive glucocorticoid therapy in patients with septic shock. N. Engl. J. Med. 378(9), 797\u2013808 (2018).","journal-title":"N. Engl. J. Med."},{"issue":"13","key":"95386_CR38","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1001\/jama.2019.11825","volume":"322","author":"AA Fowler 3rd","year":"2019","unstructured":"Fowler, A. A. 3rd. et al. Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure: The CITRIS-ALI randomized clinical trial. JAMA 322(13), 1261\u20131270 (2019).","journal-title":"JAMA"},{"key":"95386_CR39","first-page":"288","volume":"22","author":"NF Harun","year":"2019","unstructured":"Harun, N. F. et al. Intravenous thiamine as an adjuvant therapy for hyperlactatemia in septic shock patients. Crit. Care Shock 22, 288\u2013298 (2019).","journal-title":"Crit. Care Shock"},{"issue":"7","key":"95386_CR40","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1001\/jama.2020.11946","volume":"324","author":"A Moskowitz","year":"2020","unstructured":"Moskowitz, A. et al. Effect of ascorbic acid, corticosteroids, and thiamine on organ injury in septic shock: The ACTS randomized clinical trial. JAMA 324(7), 642\u2013650 (2020).","journal-title":"JAMA"},{"issue":"1","key":"95386_CR41","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.chest.2020.02.049","volume":"158","author":"J Iglesias","year":"2020","unstructured":"Iglesias, J. et al. Outcomes of metabolic resuscitation using ascorbic acid, thiamine, and glucocorticoids in the early treatment of sepsis: The ORANGES trial. Chest 158(1), 164\u2013173 (2020).","journal-title":"Chest"},{"issue":"4","key":"95386_CR42","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1080\/23744235.2020.1718200","volume":"52","author":"SJ Wani","year":"2020","unstructured":"Wani, S. J. et al. Combination of vitamin C, thiamine and hydrocortisone added to standard treatment in the management of sepsis: Results from an open label randomised controlled clinical trial and a review of the literature. Infect. Dis. (Lond.) 52(4), 271\u2013278 (2020).","journal-title":"Infect. Dis. (Lond.)"},{"issue":"8","key":"95386_CR43","doi-asserted-by":"publisher","first-page":"649","DOI":"10.5005\/jp-journals-10071-23515","volume":"24","author":"PR Reddy","year":"2020","unstructured":"Reddy, P. R., Samavedam, S., Aluru, N., Yelle, S. & Rajyalakshmi, B. Metabolic resuscitation using hydrocortisone, ascorbic acid, and thiamine: Do individual components influence reversal of shock independently?. Indian J. Crit. Care Med. 24(8), 649\u2013652 (2020).","journal-title":"Indian J. Crit. Care Med."},{"issue":"8","key":"95386_CR44","doi-asserted-by":"publisher","first-page":"653","DOI":"10.5005\/jp-journals-10071-23517","volume":"24","author":"ZU Mohamed","year":"2020","unstructured":"Mohamed, Z. U. et al. Vitamin C therapy for routine care in septic shock (ViCTOR) trial: Effect of intravenous vitamin C, thiamine, and hydrocortisone administration on inpatient mortality among patients with septic shock. Indian J. Crit. Care Med. 24(8), 653\u2013661 (2020).","journal-title":"Indian J. Crit. Care Med."},{"issue":"11","key":"95386_CR45","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1007\/s00134-020-06191-3","volume":"46","author":"SY Hwang","year":"2020","unstructured":"Hwang, S. Y. et al. Combination therapy of vitamin C and thiamine for septic shock: A multi-centre, double-blinded randomized, controlled study. Intensive Care Med. 46(11), 2015\u20132025 (2020).","journal-title":"Intensive Care Med."},{"issue":"1","key":"95386_CR46","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12871-020-01195-4","volume":"20","author":"S Petsakul","year":"2020","unstructured":"Petsakul, S. et al. Effects of thiamine on vasopressor requirements in patients with septic shock: A prospective randomized controlled trial. BMC Anesthesiol. 20(1), 280 (2020).","journal-title":"BMC Anesthesiol."},{"issue":"1","key":"95386_CR47","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.chest.2020.02.065","volume":"158","author":"P Chang","year":"2020","unstructured":"Chang, P. et al. Combined treatment with hydrocortisone, vitamin C, and thiamine for sepsis and septic shock: A randomized controlled trial. Chest 158(1), 174\u2013182 (2020).","journal-title":"Chest"},{"issue":"11","key":"95386_CR48","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3390\/medicina56110619","volume":"56","author":"A Aisa-Alvarez","year":"2020","unstructured":"Aisa-Alvarez, A. et al. Usefulness of antioxidants as adjuvant therapy for septic shock: A randomized clinical trial. Medicina (Kaunas) 56(11), 619 (2020).","journal-title":"Medicina (Kaunas)"},{"issue":"8","key":"95386_CR49","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1001\/jama.2020.24505","volume":"325","author":"JE Sevransky","year":"2021","unstructured":"Sevransky, J. E. et al. Effect of vitamin C, thiamine, and hydrocortisone on ventilator- and vasopressor-free days in patients with sepsis: The VICTAS randomized clinical trial. JAMA 325(8), 742\u2013750 (2021).","journal-title":"JAMA"},{"issue":"1","key":"95386_CR50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/cc13174","volume":"18","author":"L Mirea","year":"2014","unstructured":"Mirea, L. et al. Continuous administration of corticosteroids in septic shock can reduce risk of hypernatremia. Crit. Care 18(1), 1\u201382 (2014).","journal-title":"Crit. Care"},{"issue":"7","key":"95386_CR51","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s00134-018-5197-6","volume":"44","author":"SL Rygard","year":"2018","unstructured":"Rygard, S. L. et al. Low-dose corticosteroids for adult patients with septic shock: A systematic review with meta-analysis and trial sequential analysis. Intensive Care Med. 44(7), 1003\u20131016 (2018).","journal-title":"Intensive Care Med."},{"issue":"12","key":"95386_CR52","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1016\/j.ajem.2020.08.050","volume":"38","author":"X Qian","year":"2020","unstructured":"Qian, X., Zhang, Z., Li, F. & Wu, L. Intravenous thiamine for septic shock: A meta-analysis of randomized controlled trials. Am. J. Emerg. Med. 38(12), 2718\u20132722 (2020).","journal-title":"Am. J. Emerg. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-95386-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-95386-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-95386-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,5]],"date-time":"2023-02-05T05:08:21Z","timestamp":1675573701000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-95386-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,4]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["95386"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-95386-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,4]]},"assertion":[{"value":"24 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15777"}}